AxSpA | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

86 results for “AxSpA”

Trials

View all 53 →

axSEND: Exploring Immune and Microbiota Effects of a Partial Enteral Nutrition Diet in Axial Spondyloarthritis

62 participants · First posted Jun 14, 2024

Active, not recruiting

The REFLECT Study- Flares in axSpA

40 participants · First posted Jul 7, 2026

Psychosocial and Functional Factors in AxSpA

34 participants · First posted Nov 14, 2024

Drugs

Investigational

Vunakizumab

Conditions: Radiographic Axial Spondyloarthritis

rAAV9-CB6-AspA

ASPA gene modulator (AAV, Canavan disease)

News

View all 30 →

Certolizumab Pegol Reduces Inflammation in axSpA but Clinical Improvement Varies

Bimekizumab Demonstrates Sustained Three-Year Efficacy in Psoriatic Arthritis and Axial Spondyloarthritis

Filgotinib Meets Primary Endpoint in Phase 3 Trial for Axial Spondyloarthritis

Page 1 of 9